DalsnaFinance

Phathom Pharmaceuticals Inc $PHAT

Health Care

Russell 2000

Create a scorecard

$9.50

+0.45 (+4.97%)

As of Sep 5, 2026, 5:24 PM EDT

Price history

Loading chart…

Phathom Pharmaceuticals Inc (PHAT) is trading up at $9.50 (+4.97%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: October 25, 2019 · $19.00 offering · NASDAQ · View IPO details →

Recent News (3)

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire · 01 Sep 2026 FLORHAM PARK, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastro…
Phathom Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Phathom Pharmaceuticals (PHAT) PR Newswire · 30 Jul 2026 Phathom Pharmaceuticals guided FY 2026 revenue as high as $345 million while building out a sales force of more than 290 representatives. The revised outlook now tops out at $325 million, and PHAT sha…
Guggenheim cuts Phathom Pharmaceuticals price target on guidance reduction Investing.com · 30 Jul 2026 Guggenheim cuts Phathom Pharmaceuticals price target on guidance reduction

More Health Care stocks

Browse all companies →